| Ident. | Authors (with country if any) | Title |
|---|
| 000482 (2020) |
Jasmine R. Cleminson [Australie] ; Amanda L. Stuart [Australie] ; Julie A. Pasco [Australie] ; Jason M. Hodge [Australie] ; Michael Berk [Australie] ; Rasika M. Samarasinghe [Australie] ; Lana J. Williams [Australie] | Dietary tryptophan and bone health: a cross-sectional, population-based study. |
| 000710 (2019) |
Gerwyn Morris [Australie] ; Michael Berk [Australie] ; Michael Maes [Australie, Thaïlande] ; André F. Carvalho [Canada] ; Basant K. Puri [Royaume-Uni] | Socioeconomic Deprivation, Adverse Childhood Experiences and Medical Disorders in Adulthood: Mechanisms and Associations. |
| 000A50 (2019) |
Gerwyn Morris [Australie] ; Michael Berk [Australie] ; Michael Maes [Australie, Thaïlande] ; Basant K. Puri [Royaume-Uni] | Could Alzheimer's Disease Originate in the Periphery and If So How So? |
| 000A52 (2019) |
Michael Berk [Australie] ; Alyna Turner [Australie] ; Gin S. Malhi [Australie] ; Chee H. Ng [Australie] ; Susan M. Cotton [Australie] ; Seetal Dodd [Australie] ; Yuval Samuni [Australie] ; Michelle Tanious [Australie] ; Claire Mcaulay [Australie] ; Nathan Dowling [Australie] ; Jerome Sarris [Australie] ; Lauren Owen [Royaume-Uni] ; Astrid Waterdrinker [Australie] ; Deidre Smith [Australie] ; Olivia M. Dean [Australie] | Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo. |
| 000B63 (2019) |
Michael Berk [Australie] ; Alyna Turner [Australie] ; Gin S. Malhi [Australie] ; Chee H. Ng [Australie] ; Susan M. Cotton [Australie] ; Seetal Dodd [Australie] ; Yuval Samuni [Australie] ; Michelle Tanious [Australie] ; Claire Mcaulay [Australie] ; Nathan Dowling [Australie] ; Jerome Sarris [Australie] ; Lauren Owen [Royaume-Uni] ; Astrid Waterdrinker [Australie] ; Deidre Smith [Australie] ; Olivia M. Dean [Australie] | A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo. |
| 000F59 (2018) |
Orwa Dandash [Australie] ; Murat Yücel [Australie] ; Rothanthi Daglas [Australie] ; Christos Pantelis [Australie] ; Patrick Mcgorry [Australie] ; Michael Berk [Australie] ; Alex Fornito [Australie] | Differential effect of quetiapine and lithium on functional connectivity of the striatum in first episode mania. |
| 001098 (2017) |
Shilpa Aggarwal [Australie] ; Lian Taljard [Australie] ; Zane Wilson [Australie] ; Michael Berk [Australie] | Evaluation of Modified Patient Health Questionnaire-9 Teen in South African Adolescents. |
| 001289 (2017) |
Gerwyn Morris [Royaume-Uni] ; Michael Berk [Australie] ; Hans Klein [Pays-Bas] ; Ken Walder [Australie] ; Piotr Galecki [Pologne] ; Michael Maes [Thaïlande, Brésil, Bulgarie, Pays-Bas, Australie] | Nitrosative Stress, Hypernitrosylation, and Autoimmune Responses to Nitrosylated Proteins: New Pathways in Neuroprogressive Disorders Including Depression and Chronic Fatigue Syndrome. |
| 001474 (2017) |
Rothanthi Daglas [Australie] ; Kelly Allott [Australie] ; Murat Yücel [Australie] ; Lisa P. Henry [Australie] ; Craig A. Macneil [Australie] ; Melissa K. Hasty [Australie] ; Michael Berk [Australie] ; Sue M. Cotton [Australie] | Cognitive functioning following stabilisation from first episode mania. |
| 001640 (2016) |
Gerwyn Morris [Royaume-Uni] ; Michael Berk [Australie] ; Piotr Galecki [Pologne] ; Ken Walder [Australie] ; Michael Maes [Australie, Thaïlande, Brésil] | The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases. |
| 001644 (2016) |
Gerwyn Morris [Royaume-Uni] ; Ken Walder [Australie] ; Basant K. Puri [Royaume-Uni] ; Michael Berk [Australie] ; Michael Maes [Australie, Thaïlande, Brésil] | The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders. |
| 001752 (2016) |
Gregor E. Berger [Suisse, Australie] ; Stefan Smesny [Allemagne] ; Miriam R. Sch Fer [Australie, Autriche] ; Berko Milleit [Allemagne] ; Kerstin Langbein [Allemagne] ; Uta-Christina Hipler [Allemagne] ; Christine Milleit [Allemagne] ; Claudia M. Klier [Autriche] ; Monika Schlögelhofer [Autriche] ; Magdalena Holub [Autriche] ; Ingrid Holzer [Autriche] ; Michael Berk [Australie] ; Patrick D. Mcgorry [Australie] ; Heinrich Sauer [Allemagne] ; G Paul Amminger [Australie, Autriche] | Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis. |
| 001A24 (2016) |
Justin Davis [Australie] ; Harris Eyre [Australie] ; Felice N. Jacka [Australie] ; Seetal Dodd [Australie] ; Olivia Dean [Australie] ; Sarah Mcewen [États-Unis] ; Monojit Debnath [Inde] ; John Mcgrath [Australie] ; Michael Maes [Australie] ; Paul Amminger [Australie] ; Patrick D. Mcgorry [Australie] ; Christos Pantelis [Australie] ; Michael Berk [Australie] | A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis. |
| 001B01 (2015) |
Gerwyn Morris [Royaume-Uni] ; Michael Berk [Australie] | The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders. |
| 001D79 (2015) |
Amie C. Hayley [Australie] ; Lana J. Williams [Australie] ; Gerard A. Kennedy [Australie] ; Kara L. Holloway [Australie] ; Michael Berk [Australie] ; Sharon L. Brennan-Olsen [Australie] ; Julie A. Pasco [Australie] | Excessive daytime sleepiness and falls among older men and women: cross-sectional examination of a population-based sample. |
| 001D81 (2015) |
Rajas P. Kale [États-Unis] ; Abbas Z. Kouzani [Australie] ; Ken Walder [Australie] ; Michael Berk [Australie] ; Susannah J. Tye [États-Unis] | Evolution of optogenetic microdevices. |
| 001D82 (2015) |
Shilpa Aggarwal [Australie] ; Michael Berk [Australie] | Evolution of adolescent mental health in a rapidly changing socioeconomic environment: a review of mental health studies in adolescents in India over last 10 years. |
| 001E00 (2015) |
Stefan Smesny [Allemagne] ; Berko Milleit [Allemagne] ; Miriam R. Schaefer [Australie] ; Uta-Christina Hipler [Allemagne] ; Christine Milleit [Allemagne] ; Cornelia Wiegand [Allemagne] ; Jana Hesse [Allemagne] ; Claudia M. Klier [Autriche] ; Magdalena Holub [Autriche] ; Ingrid Holzer [Autriche] ; Michael Berk [Australie] ; Patrick D. Mcgorry [Australie] ; Heinrich Sauer [Allemagne] ; G Paul Amminger [Australie] | Effects of omega-3 PUFA on the vitamin E and glutathione antioxidant defense system in individuals at ultra-high risk of psychosis. |
| 001E54 (2015) |
Rothanthi Daglas [Australie] ; Murat Yücel ; Sue Cotton [Australie] ; Kelly Allott [Australie] ; Sarah Hetrick [Australie] ; Michael Berk [Australie] | Cognitive impairment in first-episode mania: a systematic review of the evidence in the acute and remission phases of the illness. |
| 001F11 (2015) |
Sue Lauder [Australie] ; Andrea Chester [Australie] ; David Castle [Australie] ; Seetal Dodd [Australie] ; Emma Gliddon [Australie] ; Lesley Berk [Australie] ; James Chamberlain [Australie] ; Britt Klein [Australie] ; Monica Gilbert [Australie] ; David W. Austin ; Michael Berk [Australie] | A randomized head to head trial of MoodSwings.net.au: an Internet based self-help program for bipolar disorder. |
| 002017 (2014) |
Christopher G. Davey [Australie] ; Andrew M. Chanen ; Sue M. Cotton ; Sarah E. Hetrick ; Melissa J. Kerr ; Michael Berk ; Olivia M. Dean ; Kally Yuen ; Mark Phelan ; Aswin Ratheesh ; Miriam R. Sch Fer ; G Paul Amminger ; Alexandra G. Parker ; Danijela Piskulic ; Susy Harrigan ; Andrew J. Mackinnon ; Ben J. Harrison ; Patrick D. Mcgorry | The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial. |
